# Downregulation of the Long Non-Coding RNA KLRK1-AS1 Disturbs Endothelial Barrier Integrity and Promotes Angiogenic Sprouting

**Authors:** Elisa Weiss, Azra Kulovic-Sissawo, Anke S. van Bergen, Veerle Kremer, Mariana S. Diniz, Carolina Tocantins, Susana P. Pereira, Reinier A. Boon, Ursula Hiden

PMC · DOI: 10.3390/life16020279 · Life · 2026-02-05

## TL;DR

This study shows that reducing the lncRNA KLRK1-AS1 weakens blood vessel barriers but boosts new blood vessel growth in endothelial cells.

## Contribution

Identifies KLRK1-AS1 as a novel regulator of endothelial barrier integrity and angiogenic behavior.

## Key findings

- KLRK1-AS1 knockdown reduced endothelial barrier integrity by 44%.
- Loss of KLRK1-AS1 increased angiogenic sprouting by 62%.
- KLRK1-AS1 supports a stable, quiescent endothelial phenotype.

## Abstract

Endothelial integrity is essential for cardiovascular health, and circulating endothelial progenitor cells, particularly endothelial colony-forming cells (ECFCs), are key contributors to vascular repair and maintenance. Long non-coding RNAs (lncRNAs) have emerged as novel epigenetic regulators of endothelial physiology and pathology. Building on our previous work identifying the lncRNA KLRK1-AS1 as a positive modulator of ECFC wound healing, we aimed to elucidate its role in endothelial biology. Cord blood-derived ECFCs were subjected to siRNA-mediated silencing of KLRK1-AS1, followed by blinded evaluations of monolayer morphology, barrier stability using ECIS impedance measurements, assessments of proliferation, and spheroid-based angiogenic activity. SiRNA-mediated silencing of KLRK1-AS1 induced detectable alterations in ECFC monolayer morphology (p = 0.047), while proliferation remained unaffected. Notably, KLRK1-AS1 knockdown significantly compromised endothelial barrier integrity, resulting in a 44% reduction in impedance after 48 h (p < 0.001), suggesting weakened intercellular contacts. In contrast, loss of KLRK1-AS1 enhanced angiogenic behaviour, demonstrated by an increased number of sprouts (+62%, p = 0.031). Together, these findings indicate that KLRK1-AS1 supports a quiescent, stable endothelial phenotype, with intact barrier function, while its depletion shifts ECFCs toward a more angiogenic, activated state. Our results identify KLRK1-AS1 as a previously unrecognised regulator of endothelial function.

## Linked entities

- **Genes:** KLRK1-AS1 (KLRK1 antisense RNA 1) [NCBI Gene 101928100]

## Full-text entities

- **Genes:** KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, KLRK1-AS1 (KLRK1 antisense RNA 1) [NCBI Gene 101928100] {aka TP53LC04}, RPLP0 (ribosomal protein lateral stalk subunit P0) [NCBI Gene 6175] {aka L10E, LP0, P0, PRLP0, RPP0, uL10}, H19 (H19 imprinted maternally expressed transcript) [NCBI Gene 283120] {aka ASM, ASM1, BWS, D11S813E, GMRSP, LINC00008}, MEG8 (maternally expressed 8, small nucleolar RNA host gene) [NCBI Gene 79104] {aka Bsr, Irm, LINC00024, NCRNA00024, Rian, SNHG23}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, VWF (von Willebrand factor) [NCBI Gene 399544] {aka F8VWF}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** atherosclerosis (MESH:D050197), cardiorenal syndrome (MESH:D059347), thrombotic (MESH:D013927), coronary, carotid and peripheral artery disease (MESH:D002340), CVDs (MESH:D002318), ischemic stroke (MESH:D002544), inflammation (MESH:D007249), injury to (MESH:D014947), cancer (MESH:D009369), diabetes (MESH:D003920), Endothelial dysfunction (MESH:D014652), COPD (MESH:D029424), Weight gain (MESH:D015430), non-small cell lung cancer (MESH:D002289), lung squamous cell carcinoma (MESH:D002294), neurological disorders (MESH:D009461), neuroblastoma (MESH:D009447)
- **Chemicals:** HEPES (MESH:D006531), FixDenat (-), Lipofectamine (MESH:C086724), L-cysteine (MESH:D003545), CO2 (MESH:D002245), DMSO (MESH:D004121), formaldehyde (MESH:D005557), PBS (MESH:D007854), gold (MESH:D006046), 5'-bromo-2'-deoxyuridine (MESH:D001973), nitrogen (MESH:D009584), TRIzol (MESH:C411644), methylcellulose (MESH:D008747), GlutaMAX (MESH:C054122), NaOH (MESH:D012972)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941382/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941382/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941382/full.md

---
Source: https://tomesphere.com/paper/PMC12941382